Endter Christian, Härtl Barbara, Spruss Thilo, Hauber Joachim, Dobner Thomas
Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Landshuterstrasse 22, D-93047 Regensburg, Germany.
Oncogene. 2005 Jan 6;24(1):55-64. doi: 10.1038/sj.onc.1208170.
The 55-kDa gene product from subgroup C adenovirus type 5 (Ad5) early region 1 (E1B-55kDa) plays a central role in the oncogenic transformation of primary rodent cells primarily by inactivating transcriptional and presumably other functional properties of the tumor suppressor protein p53. We have previously shown that Ad5 E1B-55kDa possesses a leucine-rich nuclear export signal (NES), which confers rapid nucleocytoplasmic shuttling via the CRM1-dependent export pathway. In this study we report that an export-deficient mutant of the viral protein (E1B-NES) substantially enhances focus formation of primary baby rat kidney cells in combination with Ad E1A. Transformed rat cells stably expressing the E1B-NES protein exhibited increased tumorigenicity and accelerated tumor growth in nude mice compared to transformants containing the wild-type E1B product. This 'gain of function' correlated with enhanced inhibition of p53 transactivation in transient reporter assays and the accumulation of the mutant protein and p53 in several dot-like subnuclear aggregates. Interestingly, these structures also contained a large fraction of cellular promyelocytic leukemia protein (PML), a known regulator of p53. These data indicate that E1B-NES promotes oncogenic transformation by combinatorial mechanisms that involve modulation of p53 in the context of PML nuclear bodies. In sum, these results extend our previous observation that inhibition of PML activities by E1B-55kDa is required for efficient focus formation and provide further support for the view that blocking p53 transcriptional functions is the principal mechanism by which the Ad protein contributes to complete cell transformation in conjunction with Ad E1A.
5型腺病毒C亚组(Ad5)早期区域1的55-kDa基因产物(E1B-55kDa)在原代啮齿动物细胞的致癌转化中起核心作用,主要是通过使肿瘤抑制蛋白p53的转录活性以及可能的其他功能特性失活来实现的。我们之前已经表明,Ad5 E1B-55kDa具有富含亮氨酸的核输出信号(NES),该信号通过依赖CRM1的输出途径赋予快速的核质穿梭能力。在本研究中,我们报告病毒蛋白的输出缺陷型突变体(E1B-NES)与Ad E1A联合使用时,能显著增强原代新生大鼠肾细胞的集落形成。与含有野生型E1B产物的转化细胞相比,稳定表达E1B-NES蛋白的转化大鼠细胞在裸鼠中表现出更高的致瘤性和更快的肿瘤生长速度。这种“功能获得”与瞬时报告基因检测中p53反式激活的增强抑制以及突变蛋白和p53在几个点状核内聚集体中的积累相关。有趣的是,这些结构中还含有很大一部分细胞早幼粒细胞白血病蛋白(PML),它是一种已知的p53调节因子。这些数据表明,E1B-NES通过涉及在PML核体背景下调节p53的组合机制促进致癌转化。总之,这些结果扩展了我们之前的观察结果,即E1B-55kDa对PML活性的抑制是有效集落形成所必需的,并进一步支持了这样一种观点,即阻断p53转录功能是Ad蛋白与Ad E1A共同促成细胞完全转化的主要机制。